Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by Pareto8020on Aug 04, 2020 11:22am
250 Views
Post# 31361269

2 DOWN 10 to GO. Time 2 put the pedal to the metal SBM.

2 DOWN 10 to GO. Time 2 put the pedal to the metal SBM. Let's hope they are still on track and will be knocking off those milestones sooner than later. 2 down / 10 to go.  Get some contracts signed with decent #'s and actualy release that info and we should be off to the races - come on Howard lets push something across the finish line we are overdue. 



https://twitter.com/SironaBiochem/status/1283748250273497094?s=20

We are happy to say that all projects are advancing as anticipated and our milestones have not changed. Thank you for the ongoing support!


Sirona anticipates achieving the following milestones in the next 12 months:
Ship first batch of TFC-1067 to Rodan + Fields for product commercialization DONE 
• Hire additional PhD staff for the scientific team at TFChem 
DONE 
• Finalize the Beijing Huaxi Pharma Co, Ltd. collaboration agreement
• Complete an additional licensing agreement for the SGLT2 inhibitor in new markets
• Secure non-dilutive funding through anticipated collaborations
• Begin large-scale manufacturing of TFC-1067 at a major manufacturer
• Finalize Tinyi agreement
• Complete a clinical trial for an increased dose of TFC-1067 (.4%)
• Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II
• Complete safety studies and enter clinical trial for anti-wrinkle compound
• Develop new anti-viral compounds and advance them into preclinical studies
• Publish in a reputable industry journal
<< Previous
Bullboard Posts
Next >>